Context Therapeutics Inc. (CNTX)
NASDAQ: CNTXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
Market open · Delayed 15 min · as of Oct 8, 11:15 AM ET
CNTX stock chart
Technical analysisKey statistics
All statistics- Market cap
- $28.53M
- EPS (TTM)
- -$0.48
- Dividend yield
- None
- 52-week range
- 0.297 – 3.62
- Day range
- 0.3085 – 0.3159
- Volume / Avg
- 111.74K / 1.83M
- Beta
- —
- Shares outstanding
- 91.88M
- Next earnings
- Nov 4, 2026
52-week range
CNTX stock today
Context Therapeutics (CNTX) is trading at $0.3105 on Oct 8, down 0.67% (-$0.0021), versus the S&P 500's 0.36% decline. Shares are 91.4% below their 52-week high of $3.62, set on Mar 16, 2026 and 4.5% above the 52-week low of $0.297, near the bottom of the past year's range. CNTX is down 78.7% year to date, underperforming the S&P 500 (+14.0%). Over the past 12 months, the stock has lost 72.3%.
Context Therapeutics has posted a net loss over the last twelve months (EPS of -$0.48), so its P/E ratio is not meaningful. Context Therapeutics's next earnings report is expected on Nov 4, 2026.
Summary generated from market data by MetaCap's automated system. Methodology
About Context Therapeutics
Company profile- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- IPO year
- 2021
Earnings
Earnings history- Next report
- Nov 4, 2026
- EPS estimate
- $-0.09
Context Therapeutics peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| MIRAMIRA Pharmaceuticals Inc. | 0.6848 | -3.55% | $28.78M | vs CNTX |
| NXTCNextCure Inc. | 6.32 | -3.71% | $28.91M | vs CNTX |
| IGCIGC Pharma Inc. | 0.2799 | -0.04% | $28.94M | vs CNTX |
| IMMPImmutep Limited ADR | 3.85 | -6.43% | $28.33M | vs CNTX |
| RNAZTransCode Therapeutics Inc. | 1.74 | -1.31% | $29.41M | vs CNTX |
| ABVCABVC BioPharma Inc. | 0.993 | -0.70% | $26.51M | vs CNTX |
| GRDXGridAI Technologies Corp. | 4.34 | +5.34% | $30.95M | vs CNTX |
| MCRBSeres Therapeutics Inc. | 2.63 | -3.31% | $26.42M | vs CNTX |
Indexes, lists and sector
Context Therapeutics stock FAQ
What is Context Therapeutics's stock price today?
CNTX last traded at $0.3105 as of Oct 8, 11:15 AM EDT, down 0.67% on the day. Prices are delayed at least 15 minutes.
When is Context Therapeutics's next earnings date?
Context Therapeutics is expected to report earnings on Wednesday, November 4, 2026. Analysts expect EPS of $-0.09.
What is the CNTX 52-week high?
The 52-week high for CNTX is $3.62 and the 52-week low is $0.297. The stock is currently 91.4% below its high.